Astragalus Membranaceus Extract Market Size, Share, Growth, and Industry Analysis, By Type (Astragalus Polysaccharide,Astragaloside IV), By Application (Healthy Food,Pharmaceutical Industry,Feed Additives,Other), Regional Insights and Forecast to 2035

Astragalus Membranaceus Extract Market Overview

The global Astragalus Membranaceus Extract Market is forecast to expand from USD 20.27 million in 2026 to USD 20.94 million in 2027, and is expected to reach USD 27.32 million by 2035, growing at a CAGR of 3.3% over the forecast period.

The global market for Astragalus membranaceus extract (AME) reached an estimated value of around USD 145.2 million in 2024. The market encompasses multiple formulations including powder, liquid, and capsules, and spans applications in health food, dietary supplements, pharmaceuticals, and cosmetics. A majority of demand is driven by rising consumer awareness of natural, plant-based immunomodulatory and antioxidant products and the broad adoption of traditional herbal medicine in both established and emerging markets.

In the United States, the market share for Astragalus membranaceus extract is part of a region that accounted for approximately 35% of global market turnover in 2023. The US contributes a substantial portion of the North American segment, where dietary supplements and functional foods containing AME are increasingly popular. The shift toward preventive health and immune support has amplified demand in the US for AME-based products, especially powdered and liquid supplement formulations.

What is Astragalus Membranaceus Extract?

Astragalus Membranaceus Extract (AME) is a herbal extract derived from the root of Astragalus membranaceus, a plant widely used in traditional medicine for its immune-supporting, antioxidant, and anti-inflammatory properties. The extract is commonly utilized in dietary supplements, functional foods, pharmaceuticals, cosmetics, and wellness products. Rich in bioactive compounds such as polysaccharides and astragalosides, AME is increasingly gaining popularity among consumers seeking natural and plant-based health solutions for preventive healthcare and overall wellness support.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 62% of global dietary supplement users prioritize immune-supporting ingredients fueling demand for Astragalus membranaceus extract.
• Major Market Restraint: Up to 70% of global Astragalus production is concentrated in specific provinces in one country, creating significant geographic supply risk.
• Emerging Trends: 92-95% bioactive-compound retention rates achieved by new extraction technologies compared to 70% previously.
• Regional Leadership: Asia-Pacific held approximately 48% of global market value in 2024.
• Competitive Landscape: The top four manufacturers globally hold more than 25% combined market share.
• Market Segmentation: In 2023, the “metal powder” (i.e., powder) sub-segment accounted for about 60% of volume share, with liquid formulations representing the remaining 40%.
• Recent Development: Extraction modernization has resulted in 60% reduction in solvent use in new manufacturing facilities worldwide.

Latest Trends

The Astragalus membranaceus extract market is witnessing a notable shift in consumer behavior, with increasing demand for natural immune-boosting supplements and botanical ingredients in functional foods. In 2023, health food applications accounted for roughly 50% of the market share, reflecting consumer preference for preventive wellness and holistic health solutions. Meanwhile, liquid and capsule forms are growing in popularity due to convenience, with the liquid sub-segment identified as the fastest-growing formulation type globally.

Innovations in extraction technology have driven improvements in product consistency and bioactive retention. Advanced methods such as ultrasonic-assisted extraction and supercritical CO₂ extraction now deliver 92–95% retention of key functional compounds a significant improvement over earlier methods that retained roughly 70%. These technological advances not only enhance the efficacy of Astragalus products but also reduce environmental footprint, by lowering solvent use by about 60%.

In parallel, product diversification into functional beverages, fortified foods, and nutraceutical lines is expanding the addressable market. For example, Astragalus-enriched beverages and health supplements are cited among the rapidly growing categories for new product launches. The increasing geriatric population worldwide particularly in North America and Europe along with rising consumer health consciousness is further driving demand for Astragalus-based immune-support solutions.

Market Dynamics

DRIVER

"Rising demand for natural immune-boosting and wellness products"

The global trend toward preventive healthcare and natural wellness is a primary driver for the Astragalus membranaceus extract market. In 2024 alone, global dietary supplement users who prioritize immune support reached 62%, significantly boosting demand for botanical extracts like Astragalus. As chronic diseases and global health concerns persist, consumers increasingly view herbal extracts as safer alternatives to synthetic drugs. This shift drives pharmaceutical-grade demand as well as nutraceutical and functional food segments.

Moreover, the growing aging demographic globally especially in developed markets underscores the need for immune-supportive, antioxidant, and anti-inflammatory supplements. The presence of bioactive constituents such as polysaccharides and astragalosides in AME, whose health benefits are increasingly validated by studies, lends credibility and fuels adoption of Astragalus-based supplements.

RESTRAINT

"Supply chain concentration and raw material variability"

A major restraint is the geographic concentration of raw-material cultivation. Approximately 70% of global supply of Astragalus raw material originates from limited regions, creating significant vulnerability to climate fluctuations, regulatory changes, and geopolitical disruptions.

Additionally, standardization remains a critical challenge: bioactive compound levels (e.g., astragaloside IV) can vary by up to 300% across different batches, complicating quality control and dosage consistency for manufacturers. Regulatory frameworks in many regions also impose strict limits on contaminants and mandate rigorous safety dossiers, which increases compliance costs and barriers especially for small-to-medium producers entering new markets.

OPPORTUNITY

"Technological innovation and new product development"

Advancements in extraction technology such as ultrasonic-assisted extraction and supercritical CO₂ extraction present significant opportunities by enabling higher bioactive retention (92–95%) compared to older methods (70%). Such consistency supports development of standardized, high-efficacy products suitable for pharmaceuticals, functional foods, and premium supplements.

There is also growing demand for Astragalus-based products beyond traditional supplement formats: functional beverages, plant-based milks, fortified juices, and cosmetics. As of 2024, about 15% of new functional beverage launches in some Western markets included botanical extracts such as Astragalus. Moreover, rising consumer preference for organic and sustainably sourced ingredients gives room for premium, traceable AME lines that meet clean-label and eco-conscious trends a segment that remains under-penetrated.

CHALLENGE

"Regulatory barriers and lack of standardization"

Regulatory complexity across geographies remains a persistent challenge. While some markets permit Astragalus as a dietary supplement, others demand extensive documentation, safety dossiers, or novel-food approvals for botanical extracts beyond traditional preparations. This increases time-to-market by 18–24 months and costs per product variant by hundreds of thousands of dollars, hindering small- and medium-sized enterprises.

Furthermore, the lack of universally accepted quality standards or pharmacopeial regulations for Astragalus extracts despite more than 50 active compounds present leads to inconsistent product efficacy and elevated recall rates. Some regulatory markets report 15–20% annual product recalls due to potency inconsistencies or contaminant levels.

Why is the Astragalus Membranaceus Extract Industry experiencing rapid growth?

The Astragalus Membranaceus Extract industry is experiencing rapid growth due to increasing global demand for natural immune-boosting and wellness products. Consumers are becoming more health-conscious and are increasingly adopting herbal supplements and plant-based ingredients as part of preventive healthcare routines. The growing popularity of functional foods, nutraceuticals, herbal beverages, and clean-label products is further driving market expansion. In addition, technological advancements in extraction methods and increasing scientific validation of Astragalus health benefits are supporting wider adoption across pharmaceutical and consumer wellness industries.

Segmentation Analysis

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Astragalus Polysaccharide: Polysaccharide-based Astragalus membranaceus extracts dominate due to their recognized immunomodulatory and antioxidant functions, supported by scientific reviews. In many reports, polysaccharide extracts are noted as the fastest-growing type over the forecast period, owing to ease of standardization and high bioactivity retention.

Astragaloside IV: Extracts standardized for astragaloside IV a saponin glycoside associated with anti-inflammatory and potential anti-aging benefits are increasingly favored for pharmaceutical-grade formulations. However, variability remains a concern, with reported batch-to-batch variation up to 300%, which necessitates stringent extraction controls and quality assurance.

By Application

Healthy Food: In 2023, healthy food applications (functional foods, beverages, supplements) represented about 50% of the AME market share, reflecting high consumer demand for natural wellness products. Astragalus-enhanced teas, health drinks, fortified snacks, and powders are being introduced increasingly, bridging traditional herbal use and modern dietary habits.

Pharmaceutical Industry: Pharmaceutical use is growing as clinical evidence accumulates around immune system, anti-inflammatory, and antioxidant benefits of AME. Producers targeting this segment demand standardized extracts (often polysaccharide- or astragaloside-standardized) with consistent potency to meet regulatory requirements.

Feed Additives: While feed additives represent a smaller portion compared to human health applications, studies show potential for AME to enhance immunity and growth in aquaculture (e.g., fish) when included at specific dosage levels (e.g., 1.5–4.5 g/kg feed). This opens opportunities in livestock and aquafeed sectors, especially in regions seeking antibiotic-free prophylactic alternatives.

Other Applications: Other segments include cosmetics and personal care, where AME’s antioxidant and anti-aging properties are leveraged. Also, niche applications such as traditional medicines, herbal teas, and wellness tonics continue to maintain demand, especially in markets with cultural acceptance of botanical products.

Which segment is expected to witness the fastest growth?

The healthy food, dietary supplements, and liquid formulation segments are expected to witness the fastest growth in the Astragalus Membranaceus Extract market. Functional foods, wellness beverages, and nutraceutical products are increasingly incorporating Astragalus due to rising consumer preference for natural immunity-support products. Liquid extracts and convenient supplement formats are gaining popularity because they offer ease of consumption and faster absorption. Pharmaceutical-grade standardized extracts are also emerging as a rapidly growing segment driven by increasing demand for clinically supported herbal formulations.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

In 2023, North America accounted for about 35% of global AME market revenue. The US leads the region, driven by strong consumer demand for dietary supplements and natural health products. Retail penetration through both online and offline channels supports accessibility. Regulatory recognition of herbal supplements and increasing emphasis on preventive healthcare contribute to robust demand. The region exhibits growing interest in polysaccharide-standardized and liquid-form extracts, especially for immune-support and wellness products. Market uptake is strong among adults and elderly demographics prioritizing immune health and antioxidant supplementation.

Europe

Europe contributes roughly 20% of global AME market share. Demand is rising, particularly for standardized extracts compliant with European safety and novel-food regulations. Consumers lean toward clean-label, sustainably sourced herbal products, which boosts interest in organically certified AME variants. Pharmaceutical and cosmetics sectors in Europe are increasingly incorporating AME due to its antioxidant and anti-aging properties. However, stringent regulations and safety dossiers pose entry barriers for smaller producers.

Asia-Pacific

Asia-Pacific remains the regional leader, holding around 48% of global AME market value in 2024. Traditional herbal medicine practices, especially in China and India, drive high demand. Government support for herbal medicine industries, widespread cultivation of Astragalus, and cultural acceptance underpin the market’s dominance. Functional foods, traditional tonics, and supplement formulations are common across the region. Rapid urbanization and rising disposable incomes further fuel adoption in both domestic consumption and exports. Local manufacturers benefit from established supply chains and large-scale raw material availability.

Middle East & Africa

Although currently the smallest region in terms of share collectively representing around 5% in 2023 the Middle East & Africa segment is gradually emerging due to rising health awareness and growing interest in natural remedies. Demand is slowly rising for dietary supplements and traditional herbal formulations. However, limited distribution networks, regulatory complexity, and lower consumer purchasing power compared to developed markets remain constraints.

Which region holds the largest market share?

Asia-Pacific holds the largest share of the global Astragalus Membranaceus Extract market due to strong traditional herbal medicine practices, extensive cultivation of Astragalus, and well-established manufacturing capabilities in the region. Countries such as China, Japan, South Korea, and India contribute significantly to both production and consumption of Astragalus-based products. Rising health awareness, growing demand for herbal supplements, and increasing use of botanical ingredients in functional foods and pharmaceuticals continue to strengthen the region’s leading position in the global market.

List of Top Astragalus Membranaceus Extract Companies

• Euromed SA
• XI`AN GAOYUAN BIO-CHEM
• World-way Biotech
• Zhe Jiang Skyherb Biotechnology
• Xinxiang Bokai Biological
• Acetar Bio-Tech
• Ningxian hengrui kang biological
• Shaanxi Jiahe Phytochem
• Xi'an Rainbow Biotech
• CHANGSHA ORGANIC HERB
• Xi`an Green Spring Technology
• Inner Mongolia Ever Brilliance Biotechnology

Top Two Companies with Highest Market Share:

• Euromed SA Top-tier global manufacturer with leading share of the standardized extract segment.
• XI`AN GAOYUAN BIO-CHEM Among the highest volume producers of Astragalus membranaceus extract, especially in polysaccharide and astragaloside-standardized extracts.

Investment Analysis and Opportunities

The Astragalus membranaceus extract market presents compelling investment opportunities for companies seeking to enter or expand in the natural health and nutraceutical space. Given that global market size in 2024 is estimated at approximately USD 145.2 million and is projected to grow significantly, firms investing in standardized extraction technologies, quality control, and sustainable sourcing stand to capture market share.

Investment in advanced extraction facilities such as ultrasonic-assisted or supercritical CO₂ extraction systems offers a competitive edge by delivering high bioactive retention (92–95%) and consistent potency, which are critical for premium end-products targeting pharmaceuticals, functional foods, and cosmetics.

Further, investments in organic cultivation, supply-chain traceability, and certification (e.g., GMP, organic, contaminant-free) could tap into rising consumer demand for clean-label, ethically sourced botanical products. The emerging feed additive application (e.g., aquaculture) offers a relatively under-exploited niche with potential for diversification.

Finally, as markets in Europe, Middle East & Africa, and emerging economies begin to adopt herbal supplements at higher rates, early investment in distribution networks, regulatory compliance, and localized production could yield long-term returns particularly for companies with capacity to provide standardized, high-quality AME products.

New Product Development

Innovation in the Astragalus membranaceus extract market has accelerated over recent years. Manufacturers are shifting from traditional powder formulations to advanced delivery formats such as liquid tinctures, standardized capsule extracts, and fortified functional beverages. This diversification broadens appeal among consumers seeking convenience, rapid absorption, and integration into everyday diets.

Advances in extraction technology notably ultrasonic-assisted extraction and supercritical CO₂ methods have enabled retention of 92–95% of bioactive compounds compared to 70% with traditional extraction. These high-efficacy extracts support premium positioning in pharmaceuticals and high-end nutraceuticals, enabling formulation of standardized-dose products with greater consistency and therapeutic reliability.

Manufacturers are also exploring pleiotropic applications of AME: combining it with other botanical extracts or vitamins for synergistic immune support, adapting it for use in skin-care and anti-aging products, and integrating it into plant-based milk, energy drinks, and wellness beverages. Such product innovation expands the addressable market beyond traditional supplement users to mainstream consumers and lifestyle-oriented demographics.

Five Recent Developments (2023–2026)

• Several leading producers invested a combined over USD 50 million in modern extraction facilities in 2024–2026 to enable standardized Astragalus extract production with high bioactive compound retention.
• New liquid-form Astragalus extracts gained market traction, with the liquid sub-segment identified globally as the fastest-growing formulation type as of 2023.
• Entry of Astragalus-enriched functional beverages and fortified food products increased about 15% of new functional-beverage launches in some Western markets included botanical extracts like Astragalus in 2024.
• Scientific literature in 2026 confirmed the wide range of bioactivities of Astragalus polysaccharides, reinforcing market confidence in immune support and antioxidant applications.
• Inclusion of Astragalus membranaceus extract in aquafeed formulations (e.g., fish diets) demonstrated measurable improvements in growth performance, digestive enzyme activity, antioxidant capacity, and immunity when AME was dosed at 1.5–4.5 g/kg feed.

Report Coverage

The Astragalus membranaceus extract market report provides comprehensive coverage by dissecting the market across multiple dimensions: product type (e.g., polysaccharide-based, astragaloside-standardized), formulation (powder, liquid, capsule), application (healthy food, pharmaceuticals, feed additives, others), distribution channel (online vs offline), and region (North America, Europe, Asia-Pacific, Middle East & Africa, Latin America).

The report includes historical data (2019–2024), market size and forecast (2026–2033), as well as segmentation by product type and application. It assesses competitive landscape, top players, market share distribution, and regional contribution offering key insights for strategic planning. It also examines market dynamics: growth drivers, restraints, opportunities, and challenges. Technological advances in extraction, regulatory considerations, supply-chain concentration, and quality standardization issues are analyzed to guide risk assessment and investment decisions. Finally, the report expands scope to emerging applications including feed additives and cosmetics beyond traditional supplement and pharmaceutical uses, highlighting new territories for business expansion and R&D-based product innovation.

Astragalus Membranaceus Extract Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 20.27 Million in 2026
Market Size Value By	USD 27.32 Million by 2035
Growth Rate	CAGR of 3.3% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Astragalus Polysaccharide Astragaloside IV By Application : Healthy Food Pharmaceutical Industry Feed Additives Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample